The COVID-19 pandemic required laboratories to operate at a record scale in a reduced timelines creating more potential opportunities for accidental template contamination. Three basic recommendations ...
Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...
In this webinar, Victoria Quiett of Thermo Fisher Scientific will dive into a comprehensive look at key components of running Pharmacogenomics (PGx) in your lab. The webinar will discuss the ...
AMES, Iowa – A machine that holds more than 5,000 samples on a plate no wider than a couple of postage stamps is among the innovations that could vastly enhance molecular diagnostic testing capacity ...
The EXPANDIA project demonstrates how cross-sector partnerships and RT-LAMP diagnostics can expand testing capacity in ...
CARLSBAD, Calif.--(BUSINESS WIRE)--To help molecular diagnostic manufacturers and clinical testing laboratories adapt to higher-standard In Vitro Diagnostic Requirements (IVDR) now in effect in the ...
Daniel Blanchard (left) is a molecular biologist and geneticist by training who, before joining Thermo Fisher Scientific (MA, USA), spent many years in academia, working mainly on RNA biology, RNAi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results